House Bill 61

150th General Assembly (2019 - 2020)

Bill Progress

Signed 6/19/19
The General Assembly has ended, the current status is the final status.

Bill Details

2/28/19
Sen. Walsh, Lopez
Rep. Briggs King
AN ACT TO AMEND TITLE 16 OF THE DELAWARE CODE RELATING TO THE UNIFORM CONTROLLED SUBSTANCES ACT.
Benzodiazepine drugs that are approved for medical use in the United States are classified by the federal Drug Enforcement Agency as Schedule IV. Fourteen benzodiazepine drugs are currently listed on Schedule IV of the Uniform Controlled Substances Act, § 4720 of Title 16. Benzodiazepine drugs have a serious potential for abuse. This Act adds both additional benzodiazepine drugs by name and the category of benzodiazepine drugs to Schedule IV of the Uniform Controlled Substances Act so that all current and future benzodiazepine drugs are included on Schedule IV in Delaware, whether or not the specific drug is approved for medical use in the United States.
82:55
11
Not Required
6/19/19
N/A

Bill Text

View HTML View PDF
You may need to disable your browser's pop-up blocker to view linked documents.

Session Laws

You may need to disable your browser's pop-up blocker to view linked documents.

Amendments

AmendmentStatusIntroduction DatePrimary SponsorView Details

Committee Reports

DateCommittee# MembersFavorableOn Its MeritsUnfavorable 

Roll Calls

ChamberResultDateVote TypeYesNoNot VotingAbsentPDF

Actions History

DateAction

Legislation Detail Feeds